Everolimus Rescue Immunosuppression in the Treatment of Chronic Allograft Dysfunction in Renal Transplant Recipients
NCT01046045
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Chronic Allograft Dysfunction in Renal Transplantation
Interventions
DRUG:
everolimus
Sponsor
Chinese University of Hong Kong